Last updated: February 6, 2024
Sponsor: Bournemouth University
Overall Status: Suspended
Phase
N/A
Condition
Vascular Diseases
Stress
High Blood Pressure (Hypertension - Pediatric)
Treatment
Slow and deep breathing
Clinical Study ID
NCT04059822
251062
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosed with pregnancy-induced hypertension (PIH). Defined as "new hypertensionpresenting after 20 weeks of pregnancy without significant proteinuria (urinaryprotein:creatinine ratio greater than 30mg/mmol" by NICE guidelines (2010) ORdiagnosed as having one-off high blood pressure but at risk of developing PIH;
- Single pregnancy;
- Capable of giving informed consent;
- Age over 18.
Exclusion
Exclusion Criteria:
- Under 18 years old;
- Referred immediately to obstetric-care after PIH diagnosis for an immediateintervention, with systolic blood pressure over 160 mmHg or diastolic blood pressureover 100 mmHg;
- Multiple pregnancy (twins, triplets, etc.);
- Current smoker;
- Current diagnosis of respiratory diseases; asthma, COPD (Chronic Obstructive Pulmonarydisease), bronchitis. (A previous occurrence or diagnosis that has not been presentfor longer than 1 year ago does not exclude participants, i.e. childhood asthma);
- Allergy/reaction to gel used on ECG tabs;
- Vulnerable participants who are unable to give informed consent.
Study Design
Total Participants: 67
Treatment Group(s): 1
Primary Treatment: Slow and deep breathing
Phase:
Study Start date:
January 14, 2020
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
Bournemouth University
Bournemouth, BH8 8GP
United KingdomSite Not Available
University Hospitals Dorset NHS Foundation Trust
Poole,
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.